Trial intelligence / Profile preview

Different doses of mannitol for intraoperative brain relaxation in supratentorial tumor surgery

ChiCTR-TRC-13003984Phase 4Completed

Sponsor
Beijing Tiantan Hospital
Start
Jan 2017
Modality
Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of Bronchitol in supratentorial neoplasm (4 arms), sponsored by Beijing Tiantan Hospital. Primary endpoints: brain relaxation and patient outcome. Started Jan 2017; status: completed.

02

Drugs

Bronchitol
03

Conditions

supratentorial neoplasm

Beyond the preview

Go deeper on ChiCTR-TRC-13003984.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-13003984.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call